Quince Therapeutics, Inc.

Historical 13F Holders

Symbol
QNCX
CUSIP
22053A107
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 6 330 k $544 k
2025 Q1 39 5.23 M $6.96 M
2024 Q4 40 5.11 M $9.55 M
2024 Q3 36 5.19 M $4.04 M
2024 Q2 49 6.26 M $4.69 M
2024 Q1 52 7.29 M $7.73 M
2023 Q4 48 7.46 M $7.84 M
2023 Q3 44 7.50 M $8.40 M
2023 Q2 45 8.98 M $13.5 M
2023 Q1 51 7.68 M $12.0 M
2022 Q4 57 5.46 M $3.48 M
2022 Q3 69 9.32 M $12.4 M
2022 Q2 80 11.7 M $26.0 M
2022 Q1 104 16.9 M $99.5 M
2021 Q4 133 19.7 M $249 M
2021 Q3 164 19.2 M $1.76 B
2021 Q2 121 18.5 M $983 M
2021 Q1 102 18.7 M $674 M
2020 Q4 99 17.7 M $491 M
2020 Q3 94 16.5 M $827 M
2020 Q2 85 15.5 M $715 M
2020 Q1 69 11.5 M $523 M
2019 Q4 54 10.7 M $600 M
2019 Q3 43 5.85 M $145 M
2019 Q2 39 2.46 M $104 M